China Weight-Loss Drug Stocks Lose Shine on ‘Misleading’ Claims
One of the few bright spots in China’s battered equity market is evaporating, with weight-loss drugs plunging after
2023-10-17 14:54
Novo Nordisk in $1.3 billion deal to buy hypertension drug
COPENHAGEN Novo Nordisk has agreed to buy ocedurenone, a drug for uncontrolled hypertension with potential application in cardiovascular
2023-10-16 19:23
LVMH Sales Growth Slows as Global Luxury Demand Cools
LVMH shares fell after the world’s largest luxury group reported softer sales growth in the third quarter —
2023-10-11 15:58
Novo’s Blockbuster Ozempic Now Shows Kidney Promise, Hitting Rivals
Novo Nordisk A/S said a kidney failure study of its diabetes drug Ozempic showed effectiveness surprisingly early, sending
2023-10-11 15:47
Ozempic Is Causing ‘Slight Pullback’ by Shoppers, Walmart Says
Walmart Inc. says it’s already seeing an impact on shopping demand from people taking the diabetes drug Ozempic,
2023-10-05 04:18
Weight-Loss Drugmaker Carmot Therapeutics Is Considering IPO
Weight-loss drugmaker Carmot Therapeutics is exploring an initial public offering, according to people with knowledge of the matter.
2023-09-30 05:57
Weight-Loss Drugs Pose Risks for People Over 65, Experts Say
It may come as a surprise, but not all weight loss is healthy. And one key question for
2023-09-28 02:57
The maker of Wegovy and Ozempic is now Europe's most valuable company
Novo Nordisk has dethroned Bernard Arnault's luxury goods giant LVMH as Europe's most valuable company.
2023-09-05 19:21
Novo’s Obesity Drug Arrives in UK – at a Fraction of US Prices
People struggling to lose weight in the UK are finally able to get their hands on the weight-loss
2023-09-05 01:27
Wegovy makes UK weight-loss debut even as Novo struggles with supplies
By Maggie Fick LONDON Some Britons are set to be able to get Wegovy weight-loss injections after Novo
2023-09-04 23:58
Drugmaker Novo Nordisk overtakes LVMH as Europe's most valuable company
By Lucy Raitano and Danilo Masoni LONDON (Reuters) -Danish drugmaker Novo Nordisk unseated LVMH as Europe's most valuable listed company
2023-09-02 00:27
Ozempic Could Be The Next Target of Medicare Price Negotiations
Ozempic, Novo Nordisk A/S’s popular diabetes drug that’s also used for weight loss, could be one of the
2023-08-30 01:53